Zimmer Biomet Holdings, Inc. announced on July 11, 2025, that it has entered a merger agreement with Monogram Technologies Inc., where Monogram will be merged into Zimmer Biomet's subsidiary, with shareholders receiving cash payments of $4.04 for common stock, $2.25 for Series D preferred stock, and $100.00 for Series E preferred stock.